Levetiracetam Mechanisms in Focal Seizure Control: SV2A Binding, GABA Enhancement, and Ion Channel Modulation
Levetiracetam (Keppra) exerts antiseizure effects through multiple synergistic mechanisms:
- SV2A Binding: High-affinity binding to synaptic vesicle protein 2A → inhibits presynaptic Ca²⁺ influx → reduces excitatory neurotransmitter (glutamate, aspartate) release.
- GABAergic Potentiation: Increases GABAₐ receptor sensitivity → enhances inhibitory chloride conductance.
- Voltage-Gated Ion Channel Modulation: Inhibits N-type and P/Q-type Ca²⁺ channels; modulates K⁺ channels → stabilizes neuronal membranes, reduces hyperexcitability.
- Additional Actions: May influence serotonergic, dopaminergic, and GABA₈ systems; exact contributions under investigation.
Unique among AEDs, levetiracetam lacks classical sodium channel blockade, contributing to its favorable side-effect profile.
Neurological Disorders - Related Articles
- Focal Epilepsy (Partial Seizures): Causes, Symptoms & Treatment
- Understanding Amyotrophic Lateral Sclerosis (ALS): Types and Progression
- Understanding Epilepsy: Management & Seizure Control
- Peripheral Neuropathy: Over 100 Types—Common Categories and Features
- Understanding the Long-Term Impact of Developmental Delays
- Understanding Nocturnal Seizures: Causes, Symptoms & Treatment
- Understanding Mild Cerebral Palsy: Causes, Symptoms & Support